Soleno Therapeutics, Inc. (SLNO) Under Investigation After Scorpion Capital Report Raises Drug Safety Concerns; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Core Insights - Gibbs Mura is investigating legal claims on behalf of investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) [1] Company Summary - Soleno Therapeutics, Inc. is currently under investigation for potential legal claims related to its operations and investor relations [1] Industry Context - The investigation highlights ongoing scrutiny within the biotechnology sector, particularly regarding investor protection and corporate governance practices [1]